Items 11 to 17 of 17 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Motesanib Diphosphate | 857876-30-3 | sc-364541 sc-364541A | 5 mg 10 mg | $255.00 $480.00 | ||
Motesanib Diphosphate functions as a potent acid halide, characterized by its ability to form stable complexes with metal catalysts, enhancing reaction efficiency. Its unique electronic structure facilitates selective nucleophilic attack, leading to distinct reaction pathways. The compound's solubility profile allows for varied reactivity in different solvent systems, influencing kinetic parameters and product distribution. This versatility makes it an intriguing subject for further exploration in synthetic methodologies. | ||||||
PF 477736 | 952021-60-2 | sc-362781 sc-362781A | 5 mg 25 mg | $113.00 $423.00 | ||
PF 477736 acts as a notable acid halide, exhibiting a propensity for rapid acylation reactions due to its electrophilic nature. Its unique steric and electronic properties enable it to engage in specific interactions with nucleophiles, promoting regioselectivity in synthetic pathways. The compound's reactivity is influenced by solvent polarity, which modulates its kinetic behavior and product formation, making it a compelling candidate for studying reaction dynamics in organic synthesis. | ||||||
4,4′-Bis(4-aminophenoxy)biphenyl | 13080-85-8 | sc-267771 | 5 g | $100.00 | ||
4,4'-Bis(4-aminophenoxy)biphenyl serves as a versatile acid halide, characterized by its ability to form stable intermediates through hydrogen bonding interactions. This compound demonstrates a unique capacity for facilitating nucleophilic substitutions, driven by its electron-rich aromatic system. The presence of multiple functional groups enhances its reactivity, allowing for diverse synthetic applications. Additionally, its solubility in various solvents influences its reactivity profile, making it an intriguing subject for mechanistic studies in organic chemistry. | ||||||
AP 24534 | 943319-70-8 | sc-362710 sc-362710A | 10 mg 50 mg | $172.00 $964.00 | 2 | |
AP 24534 (Ponatinib) can inhibit multiple tyrosine kinases, including RET, disrupting its downstream effects. | ||||||
VEGFR Tyrosine Kinase Inhibitor V | 861874-34-2 anhydrous | sc-356190 | 5 mg | $240.00 | ||
VEGFR Tyrosine Kinase Inhibitor V exhibits distinctive reactivity as a Ret, showcasing a propensity for selective binding to specific tyrosine residues. Its unique structural features enable it to modulate signaling pathways effectively, influencing cellular responses. The compound's kinetic behavior reveals a rapid association with target proteins, while its conformational flexibility allows for adaptive interactions. This dynamic nature makes it a compelling candidate for exploring intricate biochemical mechanisms. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $150.00 $920.00 | 5 | |
Sunitinib, Free Base, demonstrates remarkable characteristics as a Ret, characterized by its ability to form stable complexes with key protein targets. Its unique molecular architecture facilitates specific interactions with hydrophobic pockets, enhancing binding affinity. The compound exhibits a notable rate of dissociation, allowing for transient yet impactful modulation of cellular pathways. Additionally, its solubility profile supports diverse experimental conditions, making it a versatile tool for studying protein dynamics. | ||||||
Regorafenib | 755037-03-7 | sc-477163 sc-477163A | 25 mg 50 mg | $320.00 $430.00 | 3 | |
Regorafenib is a kinase inhibitor with activity against RET, leading to suppression of its downstream signaling. |